Patient Enrollment Marketing for Phase II COPD Drug Study- US & Canada

February 9, 2018

 

Challenge

Randomize 200 subjects in 45 days, including obtaining IRB approval, and launching the recruitment program within 30 days of contract signing.

Solution

ThreeWire developed radio, television and print ads, as well as a dedicated study website and patient portal. Respondents were pre-screened at our Patient Interaction Center® and referred as appropriate to approximately 75 sites.

Results

More than 4,000 screenings were completed in three weeks. Recruitment goals were reached two weeks ahead of schedule, with ThreeWire’s contribution of 95 patients.

Previous Flipbook
Patient Enrollment Marketing for Phase II Hypertension Study
Patient Enrollment Marketing for Phase II Hypertension Study

Assist the sponsor with meeting enrollment timelines and goals for two rescue studies at 80 sites without u...

Next Flipbook
Patient Enrollment Marketing for Phase III Oncology Drug Study- US & Europe
Patient Enrollment Marketing for Phase III Oncology Drug Study- US & Europe

Create an effective strategy for sites in the US and Europe, considering high sensitivity with Oncology sit...